Key result
SynCardia total artificial heart achieves ~73% 1-year survival as a bridge to transplantation.
Why the study?
The total artificial heart is used for patients with severe biventricular failure or structural heart issues precluding left ventricular assist device use, but detailed clinical outcomes and device options require summarization.
Population
Patients with severe biventricular failure or structural heart issues precluding LVAD use, mostly INTERMACS profile 1 or 2
Comparison
Not applicable; review of total artificial heart devices
Design
Review article
Follow-up
1 year survival data reported for experienced centers
Authors
Loading...
Supports total artificial heart bridging in experienced centers for biventricular failure; leaves open questions on generalizability and comparative effectiveness.
The total artificial heart serves as a viable bridge to transplantation for patients with severe biventricular failure, achieving a 73% 1-year survival rate in experienced centers.
Francisco A. Arabía (2020) conducted a review in Severe biventricular failure or structural heart issues. Total artificial heart (SynCardia temporary TAH) was evaluated on 1-year survival. The SynCardia temporary total artificial heart provides a 1-year survival rate of 73% in experienced centers for patients with severe biventricular failure bridging to transplantation.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: